Related Experiment Video
Updated: Mar 28, 2026

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus
Published on: May 13, 2021
Higher Throughput Quantification of Neutralizing Antibody to Herpes Simplex Viruses
Tamara P Blevins1, Michelle C Mitchell1, Maria Korom2
1Department of Internal Medicine, Division of Infectious Diseases, Saint Louis University School of Medicine, St. Louis, Missouri, United States of America.
A new rapid assay accurately measures neutralizing antibodies to herpes simplex virus (HSV) in human sera. Optimized with complement, it enhances detection, especially for HSV-2, and improves comparison across virus isolates.
Area of Science:
- Virology
- Immunology
- Assay Development
Background:
- Accurate measurement of neutralizing antibodies is crucial for understanding herpes simplex virus (HSV) immunity.
- Existing methods for quantifying HSV neutralizing antibodies can be time-consuming and lack throughput.
- The Herpevac Trial for Women provided valuable clinical isolates and sera for immunological studies.
Purpose of the Study:
- To develop and optimize a rapid, high-throughput colorimetric assay for measuring neutralizing antibodies to HSV in human sera.
- To enhance the sensitivity and reliability of HSV neutralizing antibody detection.
- To investigate the effect of assay conditions, including complement and virus source, on antibody titer measurements.
Main Methods:
- A colorimetric assay utilizing the ELVIS cell line, which expresses beta-galactosidase upon HSV infection, was employed.
- Assay conditions were optimized, including the addition of guinea pig complement and the use of virus from cell supernatant.
- Incubation times for both the assay and substrate were adjusted to achieve a standard optical density of 1.0 for reliable comparisons.
Main Results:
- The optimized assay demonstrated rapid and higher throughput measurement of HSV neutralizing antibodies.
- Addition of guinea pig complement significantly enhanced neutralizing antibody titers, particularly for HSV-2.
- Using virus from cell supernatant, rather than cell lysate, yielded higher antibody titers.
- Complement enabled sera from HSV-2 gD-vaccinated subjects to neutralize both HSV-1 and HSV-2 with equal potency.
Conclusions:
- The developed colorimetric assay provides a reliable and efficient method for quantifying HSV neutralizing antibodies.
- Complement significantly improves the detection of neutralizing antibodies, especially against HSV-2, and equalizes potency against HSV-1 and HSV-2.
- This optimized assay facilitates better comparison among different virus isolates and is valuable for immunological studies of HSV.
Related Concept Videos
Cross-reactivity
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Hypersensitivity Reactions: Cytolytic Reactions
Humoral Immune Responses
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation,...

